Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 15:00 (CEST) to 12 May 2026, 16:00 (CEST)

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 12, Status: Authorised

Referral: Sodium oxybate-containing syrup and oral solution for alcohol dependence, sodium oxybate Article 31 referrals Under evaluation, 30/06/2026

Referral: Ipidacrine-containing medicinal products, ipidacrine Article 31 referrals Under evaluation, 30/06/2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2026, 15:00 (CEST) to 13 May 2026, 16:00 (CEST)

Product Management Service (PMS) information day 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 June 2026, 08:45 (CEST) to 9 June 2026, 17:00 (CEST)